InVivo Therapeutics receives patent NOA

|About: InVivo Therapeutics Ho... (NVIV)|By:, SA News Editor

The USPTO issues a Notice of Allowance (NOA) to InVivo Therapeutics Holdings (OTCQB:NVIV +1.2%) for its patent application No. 14/177,888 titled "Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries."

The application covers the company's Neuro-Spinal Scaffold and the scaffold combined with stem cells which is being developed for the treatment of chronic spinal cord injury.